Quantcast
Home > Quotes > BPTH

Bio-Path Holdings, Inc. (DE) Common Stock (BPTH) Quote & Summary Data

BPTH 
$1.87
*  
0.03
1.58%
Get BPTH Alerts
*Delayed - data as of Apr. 20, 2018  -  Find a broker to begin trading BPTH now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
20
Today's High / Low
$ 1.92 / $ 1.73
Share Volume
348,336
50 Day Avg. Daily Volume
395,124
Previous Close
$ 1.90
52 Week High / Low
$ 7.30 / $ 1.535
Market Cap
21,207,214
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.19

Special Dividend Data

Special Dividend
N/A
Special Dividend Date
Feb. 9, 2018
Special Dividend Payment Date
N/A

Intraday Chart

Shares Traded

Share Volume:
348,336
50 Day Avg. Daily Volume:
395,124

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
Earnings Per Share (EPS):
$ -0.70

Trading Range

The current last sale of $1.87 is 21.82% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 1.92 $ 7.30
 Low: $ 1.73 $ 1.535

Company Description (as filed with the SEC)

We are a clinical and preclinical stage oncology focused RNAi nano particle drug development company utilizing a novel technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Our drug delivery and antisense technology, called DNAbilize┬«, is a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended to protect the DNA from destruction by the body's enzymes when circulating in vivo, incorporated inside of a neutral charged lipid bilayer. We believe this combination allows for high efficiency loading of antisense DNA into non-toxic, cell-membrane-like structures for delivery of the antisense drug substance into cells. In vivo, the DNAbilize┬« delivered antisense drug substances are systemically distributed throughout the body to allow for reduction or elimination of proteins in blood diseases and solid tumors.  ... More ...  

Risk Grade

Where does BPTH fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 1.91
Open Date:
Apr. 20, 2018
Close Price:
$ 1.87
Close Date:
Apr. 20, 2018

Consensus Recommendation

Analyst Info